Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tailoring the specificity of the type C feruloyl esterase FoFaeC from Fusarium oxysporum towards methyl sinapate by rational redesign based on small molecule docking simulations.
Antonopoulou I, Hunt C, Cerullo G, Varriale S, Gerogianni A, Faraco V, Rova U, Christakopoulos P. Antonopoulou I, et al. Among authors: gerogianni a. PLoS One. 2018 May 24;13(5):e0198127. doi: 10.1371/journal.pone.0198127. eCollection 2018. PLoS One. 2018. PMID: 29795702 Free PMC article.
Phase III study comparing sequential versus alternate administration of cisplatin-etoposide and topotecan as first-line treatment in small cell lung cancer.
Baka S, Agelaki S, Kotsakis A, Veslemes M, Papakotoulas P, Agelidou M, Agelidou A, Tsaroucha E, Pavlakou G, Gerogianni A, Androulakis N, Vamvakas L, Kalbakis K, Mavroudis D, Georgoulias V. Baka S, et al. Among authors: gerogianni a. Anticancer Res. 2010 Jul;30(7):3031-8. Anticancer Res. 2010. PMID: 20683051 Clinical Trial.
A multicenter randomized phase II study of the irinotecan/gemcitabine doublet versus irinotecan monotherapy in previously treated patients with extensive stage small-cell lung cancer.
Pallis AG, Agelidou A, Agelaki S, Varthalitis I, Pavlakou G, Gerogianni A, Papakotoulas P, Rapti A, Chandrinos V, Christophyllakis C, Georgoulias V. Pallis AG, et al. Among authors: gerogianni a. Lung Cancer. 2009 Aug;65(2):187-91. doi: 10.1016/j.lungcan.2008.11.002. Epub 2008 Dec 18. Lung Cancer. 2009. PMID: 19100647 Clinical Trial.
Symptom improvement in lung cancer patients treated with erlotinib: quality of life analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR.21.
Bezjak A, Tu D, Seymour L, Clark G, Trajkovic A, Zukin M, Ayoub J, Lago S, de Albuquerque Ribeiro R, Gerogianni A, Cyjon A, Noble J, Laberge F, Chan RT, Fenton D, von Pawel J, Reck M, Shepherd FA; National Cancer Institute of Canada Clinical Trials Group Study BR.21. Bezjak A, et al. Among authors: gerogianni a. J Clin Oncol. 2006 Aug 20;24(24):3831-7. doi: 10.1200/JCO.2006.05.8073. J Clin Oncol. 2006. PMID: 16921034 Clinical Trial.
13 results